Skip to main content

Levetiracetam

NDC 70069-846 · Somerset Therapeutics, LLC

Generic nameLevetiracetam in Sodium Chloride
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)LEVETIRACETAM
Strength1000 mg/100mL
Pharmacologic classDecreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

70069-846-10 — 10 POUCH in 1 CASE (70069-846-10) / 1 BAG in 1 POUCH (70069-846-01) / 100 mL in 1 BAG

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69102-108 — Levetiracetam, 69339-157 — Levetiracetam, 69367-332 — Levetiracetam, 69367-333 — Levetiracetam, 69452-412 — LEVETIRACETAM, 70010-521 — Levetiracetam, 70010-522 — Levetiracetam, 70010-523 — Levetiracetam, 70010-524 — Levetiracetam, 70069-845 — Levetiracetam in Sodium Chloride, 70069-847 — Levetiracetam in Sodium Chloride, 70518-1108 — Levetiracetam, 70518-1772 — Levetiracetam, 70518-1796 — Levetiracetam, 70518-1901 — Levetiracetam, 70518-3803 — Levetiracetam, 70518-3804 — Levetiracetam, 70518-3895 — Levetiracetam, 70518-4005 — LEVETIRACETAM, 70518-4013 — Levetiracetam, +277 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels